A tale of novel intoxication: seven cases of gamma-hydroxybutyric acid overdose.

STUDY OBJECTIVE: We describe seven patients presenting with combination substance abuse involving gamma-hydroxybutyric acid (GHB). METHODS: During a 3 month period, we identified consecutive patients with GHB ingestion confirmed by urine mass spectrometry presenting to a high-volume urban emergency department. RESULTS: All patients presented with acute delirium and transient but severe respiratory depression. With supportive care, including intubation and mechanical ventilation in four cases, normal mentation and respiratory function returned within 2 to 6 hours. None of these patients had documented seizures, and none of the four patients who received naloxone had a reversal response. This clinical observation supports previous experimental work in GHB-intoxicated human subjects demonstrating neither epileptiform changes on electroencephalography nor reversal with naloxone. Two findings are remarkable in this series. The first is the observation of a peculiar state of violent aggression present on stimulation of the GHB-intoxicated patient despite near or total apnea. The fact that patients fully recovered from this state may be the result of a previously demonstrated GHB hypoxia-sparing effect. The second is the observation of ECG abnormalities in several cases, including U waves in five patients. CONCLUSION: Emergency physicians should be alerted to this agent, its characteristic effects, and its potential for serious sequelae including respiratory arrest and death.

A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management.

gamma-Hydroxybutyric acid (GHB) is unfamiliar to many physicians in the United States but enjoys clinical use elsewhere for applications in resuscitation, anesthesia, and addiction therapy. Use within the United States is restricted to Food and Drug Administration-approved clinical trials for treatment of narcolepsy. Recently illicit use of GHB has emerged within the United States where it is distributed for purported euphoric and "fat-burning" metabolic effects. Clinical effects can be severe, progressing rapidly to respiratory arrest and death. We provide an updated comprehensive review of the literature with particular emphasis on toxicology, including GHB pharmacodynamics, clinical effects, and suggestions for overdose management. Recommended management of acute GHB intoxication includes prevention of aspiration, use of atropine for persistent symptomatic bradycardia, consideration of neostigmine as a reversal agent, and treatment for coingested substances. Emergency physicians are urged to become familiar with GHB because of its potential for severe morbidity as well as its potential use as a future resuscitative agent.

Development of an instrument to measure stress in the older adult.

The purpose of this study was to develop and carry out initial psychometric evaluation of a tool to measure stress in adults 65 years of age and older. The universe of stressors for this age group was elicited from 25 older adults, a literature review, and consultations with gerontological nursing experts. The stressors were ranked and weighted, using a Q-sort, by a sample of 43 adults 65 and over, resulting in the Stokes/Gordon Stress Scale (SGSS). The instrument was evaluated using reliability and validity measures. Test-retest reliability estimates yielded a Pearson's r ranging from .98 to .90. Coefficient alpha was .86. Pearson's r in a 1-year test of predictive validity was .36, p = .014; in tests of concurrent validity correlations ranged from .65 to .81. The SGSS can be used for clinical and research purposes to aid in assessing and planning care for the older individual.